Cord Plasma Eye Drops for Nerve Pain in the Eye
Part of Brain & nervous system, Eyes & vision, Pain clinical trials.
This trial tests whether special eye drops made from cord plasma (a blood product) can reduce chronic eye pain caused by damaged nerves in the cornea (the clear front part of your eye). You may qualify if you have had eye pain for at least 3 months without obvious surface damage.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Persistent eye pain for at least 3 months with symptoms like burning, stinging, or sharp sensations
- Confirmed nerve damage in the cornea visible on specialized imaging (confocal microscopy)
- Little to no visible surface damage on standard eye exams
- Willingness to receive cord plasma eye drops as treatment
- No active eye infections, blepharitis (eyelid inflammation), or other inflammatory eye diseases
- Not currently using steroid drops, immunosuppressant medications, or oral pain relievers that could interfere with results
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new non-invasive treatment (Quantum Molecular Resonance) to see if it can reduce pain and help damaged nerves in the eye heal. It may help people with long-lasting eye pain caused by nerve damage.
This study compares two treatments for neurotrophic keratitis, a condition where the cornea loses sensation. One treatment is a surgery to reconnect nerves to the eye, and the other is a special eye drop called Cenegermin. The goal is to see which works better to heal the cornea.
This trial tests an experimental eye drop (STSP-0902) for a condition called neurotrophic keratitis, where the cornea (the clear front part of the eye) gets scratches or sores because nerves are damaged. The drop contains a growth factor to help the eye heal. You might be eligible if you have a persistent scratch or sore on your cornea that has not improved for at least a week.
This trial studies whether your own platelet-rich plasma can help heal a fragile, slow-to-recover cornea caused by reduced corneal feeling (nerve damage). It may help reduce corneal erosion and improve corneal surface healing.
This trial tests a cooling treatment (EyeCool) for people with long-term pain on the eye's surface. It looks at how the treatment affects the eye's surface structure and inflammation after standard care hasn't worked well enough.
This trial tests whether a new eye drop called Lacripep can help treat neurotrophic keratitis, a rare eye condition where the cornea loses sensation and can become damaged. The study compares Lacripep to a placebo (inactive) drop to see if it improves corneal healing and vision.
Hear when a new Neuropathic Pain trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.